(MENAFN- Straits Research)
Cord Blood Banking Services Market Size Analysis
The global cord blood banking services market size was valued at USD 2.29 billion in 2025 and is projected to grow from USD 2.61 billion in 2026 to USD 7.33 billion by 2034, registering a CAGR of 13.8% during the forecast period from 2026 to 2034. North America dominated the cord blood banking services market with a market share of 38.7% in 2025.
Cord blood banking services involve the collection, processing, and long-term storage of stem cell-rich blood from a newborn's umbilical cord for potential future use in treating blood disorders, genetic diseases, immune deficiencies, and certain cancers.
Cord Blood Banking Services Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 2.29 Billion
2026 Market Size: USD 2.61 Billion
2034 Projected Market Size: USD 7.33 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 13.8%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 38.7%
Fastest-Growing Region: Asia Pacific
Asia-Pacific CAGR (2026–2034): 12.48%
Segment Insights
By Bank Type
Leading Segment: Service
Market Share in 2025: 65.8%
By Applications
Fastest-growing segment: Cancer
CAGR: 10.42% (2026-2034)
By Component
Leading Segment: Cord Blood
Market Share in 2025: 72.9%
By Services
Fastest-growing segment: Analysis
CAGR: 10.86% (2026-2034)
Download a Free Sample To learn more about this report,
Cord Blood Banking Services Market Trends
Growing Emphasis on Quality, Accreditation, and Standardized Cord Blood Banking
The cord blood banking services market is shifting toward stronger quality-management and accreditation practices across collection, processing, cryopreservation, storage, and release activities. As cord blood units may be used for hematopoietic stem cell transplantation, banks are placing greater emphasis on standardized procedures, traceability, donor screening, and product quality to meet clinical and regulatory requirements.
In August 2026, the FDA updated its product classification information for cryogenic cord blood storage containers, reflecting continued regulatory oversight of equipment used for long-term cord blood preservation.
Increasing Integration of Cord Blood Banking With Advanced Cell Therapy Applications
Cord blood banking is increasingly connected to the broader cellular-therapy ecosystem as cord-derived hematopoietic progenitor cells continue to support transplantation and related therapeutic development. This is encouraging banks to strengthen cell characterization, preservation, and distribution capabilities while improving their ability to supply clinically usable units.
In August 2026, the FDA listed DUCORD, a cord blood hematopoietic progenitor cell product, among products approved for unrelated-donor transplantation, reinforcing the clinical role of banked cord blood units.
Cord Blood Banking Services Market Dynamics
Market Drivers
Rising Use of Hematopoietic Stem Cell Transplantation Supports Cord Blood Banking Demand
Cord blood contains hematopoietic progenitor cells that can be used for transplantation in patients with certain blood, immune, and inherited disorders. The clinical use of these cells creates demand for professional collection, processing, testing, cryopreservation, storage, and distribution services provided by cord blood banks.
In February 2026, the FDA expanded the approved indications for OMISIRGE, a cord-blood-derived cellular therapy, to include adults and pediatric patients with severe aplastic anemia as well as hematologic malignancies.
Market Restraints
High Long-Term Storage and Quality-Control Requirements Increase Banking Costs
Cord blood banks must maintain controlled collection, processing, testing, cryopreservation, and long-term storage systems while preserving product integrity. These requirements involve specialized facilities, equipment, monitoring, trained personnel, and regulatory compliance, increasing the cost of maintaining stored units over extended periods.
In August 2026, the FDA maintained Class II classification for cryogenic cord blood storage containers, underscoring the equipment and regulatory controls required for long-term preservation.
Market Opportunities
Expansion of Global Cord Blood Networks Creates Opportunities for Broader Unit Access
Greater integration between cord blood banks, donor registries, and transplant centers can expand access to stored units across national borders. Standardized data, certification, and distribution processes allow banks to make cord blood inventories available to a broader transplant population, creating opportunities for services supporting international search, matching, allocation, and distribution.
In 2026, WMDA continued supporting systems that connect transplant centers with global donor and cord blood resources, strengthening international access to hematopoietic stem cell products.
Market Challenges
Maintaining Consistent Cell Quality Across Collection and Long-Term Storage Remains Difficult
Cord blood units must retain sufficient cellular quality and viability from collection through processing, cryopreservation, storage, transport, and eventual transplantation. Variations in collection conditions, processing procedures, storage controls, and release criteria can affect the suitability of units, requiring stringent quality systems throughout the banking lifecycle.
In March 2026, the FDA continued maintaining regulatory oversight of cord blood products intended for transplantation, including requirements covering donor screening, testing, manufacturing controls, and product release.
Cord Blood Banking Services Market Segmentation
By Bank Type
The service segment accounted for the largest share of the global cord blood banking services market, holding 65.8% in 2025. The segment dominates due to the increasing preference for comprehensive cord blood banking services, including collection, processing, cryopreservation, and long-term storage. Growing awareness among expectant parents, coupled with advancements in stem cell preservation technologies and the expansion of private and public banking facilities, continues to strengthen the demand for these services.
Request Customization to receive a tailored report.
By Applications
The cancer segment is expected to register the fastest growth, expanding at a CAGR of 10.42% during the forecast period (2026–2034). The growth is driven by the increasing use of cord blood stem cells in the treatment of hematological malignancies such as leukemia, lymphoma, and multiple myeloma. Ongoing advancements in stem cell transplantation and rising investments in oncology research are further supporting the adoption of cord blood banking services for cancer-related applications.
By Component
The cord blood segment held the largest share of the global market, accounting for 72.9% in 2025. The segment's dominance is attributed to the high concentration of hematopoietic stem cells found in cord blood, making it a valuable source for treating blood disorders, immune deficiencies, and inherited metabolic diseases. Increasing clinical applications and continuous progress in regenerative medicine continue to drive the demand for cord blood preservation worldwide.
By Services
The analysis segment is projected to witness the fastest growth, registering a CAGR of 10.86% during the forecast period (2026–2034). The growth is supported by the increasing need for quality assessment, infectious disease screening, stem cell viability testing, and genetic analysis before long-term cryopreservation. Growing regulatory requirements and advancements in laboratory diagnostics are encouraging cord blood banks to invest in advanced analytical services, thereby driving segment growth.
Speak to an Analyst to discuss market opportunities.
Cord Blood Banking Services Market Regional Outlook
North America Cord Blood Banking Services Market Analysis
North America dominated the global cord blood banking services market, accounting for 38.7% of the market in 2025, valued at USD 0.89 billion, and is projected to grow at a CAGR of 8.92% during the forecast period. The region's leadership is driven by the presence of well-established public and private cord blood banks, advanced healthcare infrastructure, growing awareness of stem cell preservation, and increasing investments in regenerative medicine. Rising adoption of cell and gene therapies and supportive regulatory frameworks continue to strengthen regional market growth.
United States Cord Blood Banking Services Market Insights
The U.S. cord blood banking services market was valued at USD 0.71 billion in 2025. The country dominates the regional market due to its advanced stem cell banking infrastructure, increasing clinical research in regenerative medicine, and growing adoption of cell and gene therapies. Rising awareness among expectant parents and the presence of leading cord blood banking companies continue to drive market expansion.
Canada Cord Blood Banking Services Market Insights
The Canada cord blood banking services market was valued at USD 0.18 billion in 2025. Growth is supported by expanding stem cell research, increasing public cord blood banking initiatives, and rising awareness of newborn stem cell preservation. Government support for regenerative medicine research and improving healthcare infrastructure are encouraging greater adoption of cord blood banking services.
Unlock Regional Insights to access country-level data, & regional trends.
Europe Cord Blood Banking Services Market Analysis
Europe accounted for 27.4% of the global cord blood banking services market in 2025, reaching USD 0.63 billion, and is expected to grow at a CAGR of 9.31% during the forecast period. Market growth is driven by expanding stem cell transplantation programs, increasing investments in regenerative medicine, supportive regulatory policies, and the presence of established public cord blood banking networks across the region.
United Kingdom Cord Blood Banking Services Market Insights
The UK cord blood banking services market was valued at USD 0.19 billion in 2025. Rising investments in stem cell research, growing awareness of cord blood preservation, and strong support for public banking programs are supporting market growth. The country's expanding regenerative medicine sector is further increasing demand for cord blood banking services.
Germany Cord Blood Banking Services Market Insights
The Germany cord blood banking services market was valued at USD 0.25 billion in 2025. Germany's advanced healthcare system, growing stem cell research activities, and increasing adoption of regenerative medicine continue to drive demand for cord blood banking services. The presence of established biobanking facilities further strengthens the country's market position.
Asia Pacific Cord Blood Banking Services Market Analysis
Asia Pacific held 22.6% of the global cord blood banking services market in 2025, valued at USD 0.52 billion, and is projected to grow at a CAGR of 12.48% during the forecast period. The region is experiencing rapid growth due to expanding healthcare infrastructure, increasing birth rates, rising awareness of stem cell preservation, and growing investments in regenerative medicine and biotechnology.
Japan Cord Blood Banking Services Market Insights
The Japan cord blood banking services market was valued at USD 0.16 billion in 2025. Market growth is supported by the country's advanced regenerative medicine ecosystem, increasing stem cell research, and supportive government policies for cell-based therapies. Continuous innovation in stem cell preservation technologies is further boosting demand.
China Cord Blood Banking Services Market Insights
The China cord blood banking services market was valued at USD 0.24 billion in 2025. Rapid expansion of the biotechnology industry, increasing healthcare expenditure, government support for regenerative medicine, and growing adoption of private cord blood banking services continue to drive market growth across the country.
Middle East & Africa Cord Blood Banking Services Market Analysis
The Middle East & Africa accounted for 4.5% of the global cord blood banking services market in 2025, with a market value of USD 0.10 billion, and is projected to grow at a CAGR of 8.64% during the forecast period. Increasing healthcare investments, improving awareness of stem cell preservation, and the gradual expansion of cord blood banking facilities are contributing to market growth across the region.
UAE Cord Blood Banking Services Market Insights
The UAE cord blood banking services market was valued at USD 0.04 billion in 2025. The country's expanding private healthcare sector, increasing investments in biotechnology, and government initiatives to strengthen advanced healthcare services are supporting demand for cord blood banking services.
Africa Cord Blood Banking Services Market Insights
The Africa cord blood banking services market was valued at USD 0.06 billion in 2025. Growth is driven by improving healthcare infrastructure, increasing maternal healthcare services, rising awareness of stem cell preservation, and the gradual expansion of public and private cord blood banking facilities across several African countries.
Cord Blood Banking Services Market Competitive Landscape
The global cord blood banking services market is moderately fragmented, with the presence of several international and regional companies offering private and public cord blood banking, stem cell processing, cryopreservation, and long-term storage services. Leading market participants include Cordlife Group Limited, CBR Systems Inc., Cryo-Cell International Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord Inc., Virgin Health Bank, and others.
Industry participants are focusing on expanding storage capacity, strengthening laboratory infrastructure, adopting advanced cryopreservation technologies, and forming strategic partnerships with hospitals and maternity centers. Companies are also investing in digital sample tracking systems and regenerative medicine research to enhance service quality, improve stem cell preservation, and expand their global customer base.
CBR Systems Inc.: A Leading Market Player
CBR Systems Inc. is one of the leading providers of newborn stem cell preservation services, offering cord blood and cord tissue banking for families worldwide. The company focuses on advanced stem cell processing technologies, long-term cryogenic storage, and research collaborations to support the growing adoption of regenerative medicine and personalized healthcare.
For instance, in May 2025, CBR Systems Inc. announced a research collaboration to expand the clinical use of newborn stem cells in regenerative medicine and pediatric therapies. The initiative aims to support ongoing clinical research while strengthening the company's position in the global market.
List of Key and Emerging Players in Cord Blood Banking Services Market
Cordlife Group Limited
CBR Systems Inc.
Cryo-Cell International Inc.
Cryo-Save AG
Lifeforce Cryobanks
National Cord Blood Program
ViaCord Inc.
Virgin Health Bank
Key Industry Developments
June 2026: Cordlife Group expanded its stem cell banking services by introducing advanced newborn stem cell preservation solutions and expanding laboratory capabilities across Asia.
May 2026: Cryo-Cell International launched enhanced cord blood and tissue processing technologies designed to improve stem cell recovery and long-term storage quality
October 2025: Vita 34 expanded its stem cell banking network through strategic partnerships with hospitals and maternity centers across Europe, strengthening access to cord blood banking services.
July 2025: Americord Registry introduced next-generation processing technology for cord blood and cord tissue banking, improving stem cell viability and storage efficiency.
Report Scope
Comments
No comment